Novo A/S as of Sept. 30, 2016
Portfolio Holdings for Novo A/S
Novo A/S holds 17 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF (VTI) | 21.3 | $240M | 2.2M | 111.33 | |
| Inogen (INGN) | 18.9 | $213M | 3.5M | 59.90 | |
| Ophthotech | 14.8 | $167M | 3.6M | 46.13 | |
| Colucid Pharmaceuticals | 10.7 | $120M | 3.2M | 38.15 | |
| Vanguard European ETF (VGK) | 9.1 | $102M | 2.1M | 48.73 | |
| Reata Pharmaceuticals Inc Cl A | 7.9 | $89M | 3.4M | 26.36 | |
| Corvus Pharmaceuticals (CRVS) | 4.7 | $53M | 3.2M | 16.45 | |
| Acceleron Pharma | 2.9 | $33M | 904k | 36.19 | |
| Spectranetics Corporation | 2.6 | $29M | 1.2M | 25.09 | |
| Merus N V (MRUS) | 2.1 | $24M | 1.4M | 16.75 | |
| Flexion Therapeutics | 1.9 | $21M | 1.1M | 19.54 | |
| Invuity | 1.6 | $18M | 1.3M | 13.72 | |
| Nabriva Therapeutics | 0.7 | $7.9M | 1.1M | 7.05 | |
| Wright Medical Group Rtsn V | 0.5 | $6.1M | 4.6M | 1.31 | |
| Htg Molecular Diagnostics | 0.3 | $2.9M | 1.3M | 2.27 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.0M | 128k | 8.10 | |
| Opko Health (OPK) | 0.0 | $3.0k | 259.00 | 11.58 |
